open access

Online first
Editorial
Published online: 2023-02-15
Get Citation

Apples and oranges in coronary artery disease diagnostics

Joyce Peper, LM Becker, MJ Swaans
DOI: 10.33963/KP.a2023.0044
·
Pubmed: 36791422

open access

Online first
Editorial
Published online: 2023-02-15

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Apples and oranges in coronary artery disease diagnostics

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Editorial

Published online

2023-02-15

Page views

28

Article views/downloads

22

DOI

10.33963/KP.a2023.0044

Pubmed

36791422

Authors

Joyce Peper
LM Becker
MJ Swaans

References (14)
  1. American Heart Association.. 2021 Heart Disease & Stroke Statistical Update Fact Sheet Global Burden of Disease High Blood Cholesterol and Other Lipids. Am Heart Assoc. 2021.
  2. Saraste A, Knuuti J, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407–477.
  3. Picano E, Santoro G, Vano E. Sustainability in the cardiac cath lab. Int J Cardiovasc Imaging. 2007; 23(2): 143–147.
  4. European Society of Radiology (ESR). White paper on radiation protection by the European Society of Radiology. Insights Imaging. 2011; 2(4): 357–362.
  5. Peper J, Schaap J, Kelder JC, et al. Added value of computed tomography fractional flow reserve in the diagnosis of coronary artery disease. Sci Rep. 2021; 11(1): 6748.
  6. Dębski MA, Kruk M, Bujak S, et al. Benefits of the selective invasive strategy guided by CTA and CT-FFR in patients with coronary artery disease. Kardiol Pol. 2022 [epub ahead of print].
  7. Celeng C, Leiner T, Maurovich-Horvat P, et al. Anatomical and Functional Computed Tomography for Diagnosing Hemodynamically Significant Coronary Artery Disease: A Meta-Analysis. JACC Cardiovasc Imaging. 2019; 12(7 Pt 2): 1316–1325.
  8. Zhou T, Wang X, Wu T, et al. Clinical application of computed tomography angiography and fractional flow reserve computed tomography in patients with coronary artery disease: A meta-analysis based on pre- and post-test probability. Eur J Radiol. 2021; 139: 109712.
  9. Peper J, Becker LM, van Kuijk JP, et al. Fractional flow reserve: patient selection and perspectives. Vasc Health Risk Manag. 2021; 17: 817–831.
  10. Neumann FJ, Sousa-Uva M, Neumann FJ, et al. Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of the task force of the 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019; 40(2): 204–212.
  11. Dattilo PB, Prasad A, Honeycutt E, et al. Contemporary patterns of fractional flow reserve and intravascular ultrasound use among patients undergoing percutaneous coronary intervention in the United States: insights from the National Cardiovascular Data Registry. J Am Coll Cardiol. 2012; 60(22): 2337–2339.
  12. Parikh RV, Liu G, Plomondon ME, et al. Utilization and Outcomes of Measuring Fractional Flow Reserve in Patients With Stable Ischemic Heart Disease. J Am Coll Cardiol. 2020; 75(4): 409–419.
  13. Maron D, Hochman J, Reynolds H, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020; 382(15): 1395–1407.
  14. Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018; 391(10115): 31–40.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl